SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $752,000 | -21.7% | 432,259 | +0.4% | 0.28% | +24.9% |
| Q2 2015 | $961,000 | -32.9% | 430,749 | -41.7% | 0.22% | -16.6% |
| Q1 2015 | $1,433,000 | +18.2% | 738,748 | +61.5% | 0.26% | +19.9% |
| Q4 2014 | $1,212,000 | -9.3% | 457,458 | +3.1% | 0.22% | -8.7% |
| Q3 2014 | $1,336,000 | +8.1% | 443,871 | +46.8% | 0.24% | +22.8% |
| Q2 2014 | $1,236,000 | +45.8% | 302,296 | +53.7% | 0.20% | +60.2% |
| Q1 2014 | $848,000 | +114.1% | 196,639 | +160.1% | 0.12% | +123.6% |
| Q4 2013 | $396,000 | -15.7% | 75,614 | +1.5% | 0.06% | -25.7% |
| Q3 2013 | $470,000 | +28.1% | 74,480 | +1.2% | 0.07% | +13.8% |
| Q2 2013 | $367,000 | – | 73,585 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |